Drug Profile
Research programme: conopeptide analgesics - Cognetix
Alternative Names: Conopeptide analgesics research programme - CognetixLatest Information Update: 29 Apr 2008
Price :
$50
*
At a glance
- Originator University of Utah
- Developer Cognetix
- Class Conotoxins; Peptides
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain